Glendon E. French
Net Worth
Last updated:
What is Glendon E. French net worth?
The estimated net worth of Mr. Glendon E. French is at least $19,098,391 as of 22 Nov 2024. He owns shares worth $1,640,120 as insider, has earned $14,950,991 from insider trading and has received compensation worth at least $2,507,280 in Pulmonx Corporation.
What is the salary of Glendon E. French?
Mr. Glendon E. French salary is $626,820 per year as Chief Executive Officer, Pres & Director in Pulmonx Corporation.
How old is Glendon E. French?
Mr. Glendon E. French is 63 years old, born in 1962.
What stocks does Glendon E. French currently own?
As insider, Mr. Glendon E. French owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | Chief Executive Officer, Pres & Director | 1,071,974 | $1.53 | $1,640,120 |
What does Pulmonx Corporation do?
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Glendon E. French insider trading
Pulmonx Corporation
Mr. Glendon E. French has made 53 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of LUNG stock worth $132,600 on 22 Nov 2024.
The largest trade he's ever made was exercising 50,000 units of LUNG stock on 18 Aug 2022. As of 22 Nov 2024 he still owns at least 1,071,974 units of LUNG stock.
Pulmonx key executives
Pulmonx Corporation executives and other stock owners filed with the SEC:
- Mr. David A. Lehman (64) Gen. Counsel & Sec.
- Mr. Geoffrey Beran Rose (52) Chief Commercial Officer
- Mr. Glendon E. French (63) Chief Executive Officer, Pres & Director